Tablet or capsule form of generic mycophenolate mofetil (My-Rept(®)) after liver transplantation: a prospective randomized trial

BACKGROUND: Tablet and capsule forms have advantages and disadvantages in the market. Generally, the tablet form (500 mg) of mycophenolate mofetil (MMF) is more convenient for drug ingestion and more cost-effective than the capsule form (250 mg). We examined the efficacy and safety of MMF in its dif...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Drug Des Devel Ther
Hlavní autoři: Kim, Jong Man, Oh, Jong Wook, Kim, Sangjin, Rhu, Jinsoo, Lee, Ji Soo, Kim, Kyeong Sik, Choi, Gyu-Seong, Joh, Jae-Won
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2019
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6617558/
https://ncbi.nlm.nih.gov/pubmed/31308630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S204056
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky